Covered recipient · General Payments record
ROSS PASSO
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2022–2024
$2,030.94
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $1,200.00 | 1 |
| Food and Beverage | $376.95 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| RxSight Inc | $1,200.00 | 1 |
| Alcon Laboratories Inc | $126.16 | 3 |
| ABBVIE INC. | $90.09 | 3 |
| Regeneron Healthcare Solutions, Inc. | $76.58 | 3 |
| Bausch & Lomb Americas Inc. | $21.02 | 1 |
| Thea Pharma Inc. | $16.90 | 1 |
| Amgen Inc. | $16.43 | 1 |
| GLAUKOS CORPORATION | $15.05 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.51 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189347 | CMS |
| ABBVIE INC. | $31.67 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189349 | CMS |
| ABBVIE INC. | $26.91 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189351 | CMS |
| Alcon Vision LLC | $23.94 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110705830 | CMS |
| Alcon Vision LLC | $60.30 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110705834 | CMS |
| Alcon Vision LLC | $41.92 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110705832 | CMS |
| Amgen Inc. | $16.43 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115997241 | CMS |
| Bausch & Lomb Americas Inc. | $21.02 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140438768 | CMS |
| Glaukos Corporation | $15.05 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151986492 | CMS |
| Regeneron Healthcare Solutions, Inc. | $20.15 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114131589 | CMS |
| Regeneron Healthcare Solutions, Inc. | $29.54 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114131591 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.89 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114131593 | CMS |
| RxSight Inc | $1,200.00 | 06/07/2024 | Education | Undisputed | 01/23/2026 | 1144224499 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.72 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152197475 | CMS |
| Thea Pharma Inc. | $16.90 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543831 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.